Small mature lymphocytes, CLL and MBL
14 min
Skills you'll build2 skills
- Recognize a small mature lymphocytosis that needs flow cytometry for clonality
- Name the flow cytometry result that separates CLL from monoclonal B-cell lymphocytosis
At the bench: Recognize abnormal cell findings that need further review
Try first
Get the idea
Use the explanation to check your first decision.
The CLL-compatible film
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western populations, and many patients are found through a routine CBC showing absolute lymphocytosis of small mature lymphocytes with dense, clumped chromatin and scant cytoplasm.1 Smudge cells, fragile lymphocytes broken during film preparation, are common in CLL and also occur in other lymphocytoses, so they are not specific for it.1 A compatible film pattern calls for flow cytometry.
The clonal B-cell threshold
The International Workshop on CLL (iwCLL) diagnostic threshold is at least 5 × 10³/µL clonal B cells in blood, sustained for at least 3 months.2 A lower clonal count without lymphadenopathy, organomegaly, disease-related cytopenias, or symptoms is monoclonal B-cell lymphocytosis (MBL).1 A cytopenia caused by a typical marrow infiltrate can establish CLL despite a lower blood clonal B-cell count.2 Disease-associated lymphadenopathy with a lower blood clonal count and no cytopenia from a clonal marrow infiltrate calls for assessment for small lymphocytic lymphoma (SLL), usually with tissue confirmation. Organomegaly at a lower count also requires further assessment.2 Flow cytometry demonstrates clonality by showing CD19, CD20 dim, CD23, and aberrant CD5 with dim surface immunoglobulin and light-chain restriction.1 The threshold applies to the clonal B-cell count. A lymphocytosis this size also contains T cells and NK cells, so applying the threshold to the total lymphocyte count can misclassify MBL as CLL.
Prognostic markers in CLL
Unmutated IGHV arises from a pre-germinal-center cell and behaves aggressively. Mutated IGHV arises from a post-germinal-center cell and behaves indolently, so IGHV mutation status is a major prognostic factor once CLL is established.1 TP53 disruption is a major predictive marker assessed with it.1 These markers guide risk assessment and treatment planning once the diagnosis is established. Classification as CLL, SLL or MBL depends on the clonal B-cell count, its persistence, and evidence of marrow or other tissue involvement.1,2
Follow the bench demonstration
Sources for this step
References
- Alaggio R, Amador C, Agnarsson I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720-1748. doi:10.1038/s41375-022-01620-2
- Hallek M, Cheson BD, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25):2745-2760. doi:10.1182/blood-2017-09-806398
Watch one
Read each decision and its explanation.
A CBC shows an absolute lymphocyte count of 6.2 × 10³/µL, with a film pattern of small mature lymphocytes and frequent smudge cells. Flow cytometry reports 4.1 × 10³/µL clonal B cells with a CD5-positive, CD23-positive phenotype. The patient has no lymphadenopathy, organomegaly, or cytopenias. What do you report?
- Use the clonal count from the flow result. The threshold is applied to the 4.1 × 10³/µL clonal B cells, and the 6.2 × 10³/µL total lymphocyte count is not used.
The iwCLL threshold applies to the clonal B-cell count. The total lymphocyte count is a separate number.
- Compare with the threshold. 4.1 × 10³/µL is below 5 × 10³/µL.
The iwCLL threshold is 5 × 10³/µL clonal B cells sustained for at least 3 months.
- Check for cytopenias, lymphadenopathy and organomegaly. None is present.2
A cytopenia caused by a typical marrow infiltrate can establish CLL below the blood threshold. Disease-associated lymphadenopathy at a lower count calls for SLL assessment.
Your turn
Use it
Read the case evidence, then make each decision. The step is complete without it.
- A 68-year-old man (MRN 0492117) has a CBC ordered for a routine physical.
- He reports no fatigue, weight loss, or night sweats.
- Examination notes no palpable lymphadenopathy or splenomegaly.
- Flow cytometry on the blood shows 6.4 × 10³/µL clonal B cells: CD19 positive, CD20 dim positive, CD23 positive, aberrant CD5 positive, with dim surface immunoglobulin and kappa light-chain restriction.
- A repeat CBC and flow panel 4 months later show the same clonal B-cell count and phenotype.
| Test | Result | Previous | Reference interval | Flag |
|---|---|---|---|---|
| WBC | 12.8 × 10³/µL High1 year ago: 7.1 × 10³/µL | 7.1 × 10³/µL1 year ago | 4.5–11.0 × 10³/µL4.5–11.0 | High |
| Absolute lymphocytes | 8.9 × 10³/µL High1 year ago: 2.4 × 10³/µL | 2.4 × 10³/µL1 year ago | 1.0–4.8 × 10³/µL1.0–4.8 | High |
| Hemoglobin | 14.2 g/dL1 year ago: 14.5 g/dL | 14.5 g/dL1 year ago | 13.5–17.5 g/dL13.5–17.5 | |
| Platelets | 245 × 10³/µL1 year ago: 260 × 10³/µL | 260 × 10³/µL1 year ago | 150–400 × 10³/µL150–400 |
Specimen: H 2, L 5, I 1. EDTA whole blood, drawn at the routine visit
The sustained clonal B-cell count of 6.4 × 10³/µL with the CLL phenotype, confirmed on a repeat panel 4 months later, is above the 5 × 10³/µL iwCLL threshold. CLL is reported without lymphadenopathy, organomegaly, or a cytopenia.
Review missed questions
For reference
Sources checked